Amelioration of intestinal and systemic sequelae of murine Campylobacter jejuni infection by probiotic VSL#3 treatment

BACKGROUND: The incidence of human Campylobacter jejuni infections is progressively increasing worldwide. Probiotic compounds might open up valuable tools to decrease pathogen burden and subsequent pro-inflammatory immune responses, but in vivo data are scarce. METHODS AND RESULTS: Secondary abiotic...

Descripción completa

Detalles Bibliográficos
Autores principales: Ekmekciu, Ira, Fiebiger, Ulrike, Stingl, Kerstin, Bereswill, Stefan, Heimesaat, Markus M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387377/
https://www.ncbi.nlm.nih.gov/pubmed/28413453
http://dx.doi.org/10.1186/s13099-017-0168-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387377/
https://www.ncbi.nlm.nih.gov/pubmed/28413453
http://dx.doi.org/10.1186/s13099-017-0168-y

Ejemplares similares